España 11 abreviaturas coloquiales en inglés para WhatsApp que hay que conocer.Ecuador 11 abreviaturas coloquiales en inglés para WhatsApp que hay que conocer.Deutschland 11 Abkürzungen, die du jetzt für WhatsApp kennen musst.Danmark Tbh, omw, obvs! 11 Messenger udtryk, du kommer til at mestre på en udlandsrejse.Colombia 11 abreviaturas en inglés para WhatsApp que hay que conocer.Chile 11 abreviaturas en inglés para WhatsApp.Canada (Français) 11 abréviations anglaises très utilisées sur WhatsApp.Canada 11 bits of WhatsApp slang you need to master today.Brasil Abreviações e siglas em inglês usadas no WhatsApp.Belgique 11 abréviations anglaises très utilisées sur WhatsApp.Argentina 11 abreviaturas en inglés para ser un maestro de WhatsApp.Algérie 11 abréviations anglaises très utilisées sur WhatsApp.12 0/7 to 32 0/7 weeks gestation (see Gestational Age Determination section 3.2.1.11 bits of WhatsApp slang you need to master today.To be enrolled in the study, patients must meet all of the following criteria: Achieving this goal of individualized indomethacin therapy could have a significant impact on clinical practice and improve maternal and neonatal outcomes. These covariates, if significant, can then be used in the future to optimize dosing in individual patients at risk for PTB. Quantification of the differences within and between individuals allows for identification of covariates (e.g., CYP2C9 genotype, estradiol levels, BMI, etc.) that can explain variability and affect drug exposure. The investigators will merge dosing, sampling, demographic, and clinical information with the drug concentration data and use population PK methodologies to analyze the data using nonlinear mixed effect modeling. The investigators will enroll 300 subjects with spontaneous preterm labor (sPTL) or shortened cervix in a prospective opportunistic PK study designed to correlate the PK of indomethacin, patient genotype, and clinical outcomes. This hypothesis will be tested with the following specific aims: (1) Determine the PK of indomethacin in pregnant women at risk of PTB and its PD effects on reducing the rate of PTB before 34 weeks of gestation, as well as any associations between the PK and secondary maternal/neonatal clinical outcomes (2) Determine the effects of maternal levels of estradiol in mid-pregnancy and CYP2C9 polymorphisms on indomethacin biotransformation to O-desmethylindomethacin in pregnant patients (3) Construct a population PK/PD model of indomethacin in patients at risk of PTB (12-32 weeks of gestation) in order to optimize the dose and the dosing frequency for indomethacin prescribed to each individual based on covariates such as race/ethnicity, CYP2C9 genotype, gestational age, estradiol levels, smoking status, and body mass index (BMI). Determine the pharmacokinetics, pharmacodynamics and pharmacogenomics of Indomethacin in pregnant patients with the hypothesis that that estradiol levels during pregnancy (12-32 weeks of gestation) and CYP2C9 polymorphisms affect the PK of indomethacin, and subsequently, the response to indomethacin therapy in patients at risk of Preterm birth (PTB). Opportunistic study of indomethacin prescribed to patients per standard of care. Premature Labor Pregnancy Premature Birth However, despite the widespread use of indomethacin in pregnancy, there is limited information available to help physicians determine how much indomethacin to prescribe and how often to prescribe it. Indomethacin has been used since the 1970s to prolong pregnancy by decreasing uterine contractions. Indomethacin is often prescribed to pregnant women presenting with preterm labor or shortened cervix, which places them at risk for preterm labor and delivery. This will help us develop more information for medication dosing specific to pregnant women experiencing preterm labor. This study will follow pregnant women who are taking indomethacin as Standard of Care (SOC) for the indications of preterm labor (PTL), short cervix, or other indications, to evaluate the pharmacokinetics (PK), what the body does to the drug, and pharmacodynamics (PD), effectiveness of the drug in treating the specific intended disease process of this medication. Why Should I Register and Submit Results?.